Certainly the MSI-positive phenotype is not ubiquitous in sarcoma as it is in HNPCC, which is instinctive since germline mutations of the MMR system have not been reported in sarcoma, but instead, it is more likely that MSI is observed with at least the same frequency as observed in sporadic CRC. This evidence concerns the gene MRC1 and sarcoma.